陜西(xi)合成藥(yao)(yao)(yao)(yao)業(ye)(ye)股(gu)份有限公(gong)司(si)成立(li)(li)于2014年(nian),系(xi)(xi)由2009年(nian)4月成立(li)(li)的陜西(xi)合成藥(yao)(yao)(yao)(yao)業(ye)(ye)有限公(gong)司(si)整體改制變更成立(li)(li),公(gong)司(si)于2015年(nian)3月在(zai)全國中小(xiao)企(qi)業(ye)(ye)股(gu)份轉讓系(xi)(xi)統(tong)成功掛牌(股(gu)票名(ming)稱:合成藥(yao)(yao)(yao)(yao)業(ye)(ye);股(gu)票代碼:832077),是專于藥(yao)(yao)(yao)(yao)品研(yan)(yan)(yan)究(jiu)開發(fa)(fa)(fa)(fa)、注冊(ce)申(shen)報的新(xin)藥(yao)(yao)(yao)(yao)技術企(qi)業(ye)(ye)。研(yan)(yan)(yan)發(fa)(fa)(fa)(fa)范圍涉(she)及各類化學新(xin)藥(yao)(yao)(yao)(yao),并針對目前上市(shi)的藥(yao)(yao)(yao)(yao)物缺陷(xian)進行(xing)結構(gou)修(xiu)飾,自主研(yan)(yan)(yan)發(fa)(fa)(fa)(fa)藥(yao)(yao)(yao)(yao)效更強(qiang)、安全性更高的化學新(xin)藥(yao)(yao)(yao)(yao)。目前擁有合成藥(yao)(yao)(yao)(yao)業(ye)(ye)泰州研(yan)(yan)(yan)發(fa)(fa)(fa)(fa)中心和江蘇天地人和藥(yao)(yao)(yao)(yao)業(ye)(ye)有限公(gong)司(si)子公(gong)司(si)。公(gong)司(si)本(ben)著“嚴謹、務實、創新(xin)、進步”的理(li)念,建立(li)(li)了(le)新(xin)藥(yao)(yao)(yao)(yao)項(xiang)目的情(qing)報搜集、立(li)(li)項(xiang)、研(yan)(yan)(yan)發(fa)(fa)(fa)(fa)、申(shen)報的流(liu)程(cheng)管理(li)系(xi)(xi)統(tong)完(wan)整的新(xin)藥(yao)(yao)(yao)(yao)項(xiang)目研(yan)(yan)(yan)發(fa)(fa)(fa)(fa)體系(xi)(xi)。
合(he)成(cheng)藥業(ye)是陜西省科技廳、財政廳、稅務局共同認定的高新技術企(qi)業(ye)。
公(gong)(gong)司(si)與揚子江(jiang)藥(yao)(yao)業(ye)集團、哈爾濱譽恒藥(yao)(yao)業(ye)股份有限(xian)(xian)公(gong)(gong)司(si)、武(wu)漢福星(xing)生物藥(yao)(yao)業(ye)有限(xian)(xian)公(gong)(gong)司(si)、北(bei)京(jing)(jing)凱因藥(yao)(yao)業(ye)股份有限(xian)(xian)公(gong)(gong)司(si)、西安(an)天一(yi)秦昆制藥(yao)(yao)有限(xian)(xian)責任(ren)公(gong)(gong)司(si)、北(bei)京(jing)(jing)美迪康(kang)信醫藥(yao)(yao)科技有限(xian)(xian)公(gong)(gong)司(si)等十(shi)幾家國(guo)內藥(yao)(yao)企建(jian)立了良好(hao)的合作(zuo)關系。
合成藥業(ye)將以科(ke)技創新的核(he)心(xin)動力,不斷強化核(he)心(xin)技術水平、規(gui)范經(jing)營管理(li)體系,為全人類的健康事業(ye)奮進!